Revealing never-before-reported information, the book delves into the elite interests profiting from birth control methods such as drugs, contraceptives and abortions.
This revelation coincides with recent victories for the abortion lobby, including a pro-abortion ballot measure in Ohio; the reelection of Kentucky's Democratic governor on a pro-abortion platform; and a Pennsylvania Supreme Court seat won by a Democrat committed to upholding abortion rights.
Among the revelations in "Controligarchs" is information about billionaires like George Soros and Warren Buffett seeking substantial profits through the controversial abortion drug mifepristone, utilizing a shell corporation in the Cayman Islands. (Related: Bill Gates pledges $7 billion to control population and promote abortion in Africa.)
The book also sheds light on shadowy deals between the Rockefeller Foundation and former President Bill Clinton's Food and Drug Administration (FDA) that facilitated bringing the pill to market. In November last year, the Alliance Defending Freedom filed a lawsuit against the FDA for its Clinton-era approval of the abortion-inducing drug mifepristone, formerly known as RU-486.
In April, a federal district court in Texas ruled against the FDA's "unlawful approval" of mifepristone. In September, President Joe Biden's Department of Justice and the drug's manufacturer appealed to SCOTUS to reverse the lower court's ruling, and the final fate of the drug is yet to be determined. The revelations in "Controligarchs" about the development, market-entry and secret profitability of the abortion-inducing drug add depth to the ongoing discourse.
The book explores how mifepristone, brought to America in the 1990s, was developed in collaboration with German pharmaceutical conglomerate Hoechst AG and the Rockefeller Foundation's Population Council. The book also details the meetings between Hoechst and Clinton's FDA, highlighting the controversy surrounding Hoechst's association with I.G. Farben, the German successor to the Zyklon B manufacturer.
The Rockefeller Foundation's historical connection to eugenics is also discussed. The meetings culminated in Hoechst donating patent rights for RU-486 to the Population Council, with the drug eventually reaching the market.
"Controligarchs" unravels the for-profit nature of Danco Laboratories, established in the Cayman Islands in 1995, with investors including George Soros, Warren Buffett and other billionaire elites.
What is mifepristone?
Mifepristone is a medication that blocks the hormone progesterone, which is necessary for a pregnancy to continue. It is primarily used for the medical termination of pregnancy through 10 weeks gestation.
When used in combination with another medicine called misoprostol, mifepristone is used to end pregnancy during the early part of pregnancy, up to week 10.
Mifepristone works by stopping the supply of hormones that maintain the interior of the uterus, leading to the expulsion of the contents of the uterus. It is also used to control high blood sugar in patients with Cushing's syndrome.
Drug-induced abortions, particularly those using mifepristone, now constitute more than half of all abortions in the United States. The book highlights the risks associated with such abortions and the ongoing SCOTUS decision on mifepristone's fate, expected in the coming months.
This exposes the intricate connections and covert dealings behind the scenes, illustrating how the controversial drug mifepristone has become a lucrative venture for powerful billionaires while sparking debates over reproductive rights and the future of abortion laws in the United States.
Read more stories about abortion pills at Abortions.news.
Watch this video about the SCOTUS restoring access to abortion pill Mifepristone.
This video is from the Pool Pharmacy channel on Brighteon.com.
More related stories:
Texas judge imposes nationwide block on abortion drug mifepristone; liberals melt down.
Walgreens, CVS to sell ABORTION PILLS in states where abortion is still legal.
Sources include:
Please contact us for more information.
